MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative condition that is traditionally characterized by tau and amyloid beta protein deposition in neurofibrillary tangles, gradual brain atrophy, and decline in cognitive function [1,2].